Alector (ALEC) Cash from Investing Activities (2018 - 2026)

Alector's (ALEC) quarterly Cash from Investing Activities came in at $60.9 million in Q1 2026, down 7.28% year-on-year from $65.7 million in Q1 2025, and up 138.1% on a QoQ basis from $25.6 million in Q4 2025.

Alector (ALEC) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Cash from Investing Activities data on file, last reported at $60.9 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 7.28% year-over-year to $60.9 million in Q1 2026; TTM through Mar 2026 was $191.8 million, a 3.89% increase from a year earlier, with the FY2025 full-year figure at $196.6 million, up 83.51% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $60.9 million, up from $25.6 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ALEC reached as high as $88.7 million in Q1 2023 and fell as low as -$225.8 million in Q2 2022.
  • Historically, Cash from Investing Activities has averaged $18.1 million across 5 years, with a median of $37.1 million in 2024.
  • Across the five-year window, Cash from Investing Activities slumped 499.04% in 2022 and surged 832.7% in 2023, its largest moves.
  • Year by year, Cash from Investing Activities stood at $18.4 million in 2022, then declined by 1.69% to $18.1 million in 2023, then jumped by 129.11% to $41.4 million in 2024, then tumbled by 38.17% to $25.6 million in 2025, then jumped by 138.1% to $60.9 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $60.9 million in Q1 2026, $25.6 million in Q4 2025, and $49.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Alector 166.99 Mn -39.52 Mn - 60.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.95 Mn
Mar 31, 2026 60.95 Mn
Dec 31, 2025 25.60 Mn
Dec 31, 2025 25.60 Mn
Sep 30, 2025 49.54 Mn
Sep 30, 2025 49.54 Mn
Jun 30, 2025 55.72 Mn
Jun 30, 2025 55.72 Mn
Mar 31, 2025 65.74 Mn
Mar 31, 2025 65.74 Mn
Dec 31, 2024 41.40 Mn
Dec 31, 2024 41.40 Mn
Sep 30, 2024 40.35 Mn
Sep 30, 2024 40.35 Mn
Jun 30, 2024 37.15 Mn
Jun 30, 2024 37.15 Mn
Mar 31, 2024 -11.77 Mn
Mar 31, 2024 -11.77 Mn
Dec 31, 2023 18.07 Mn
Dec 31, 2023 18.07 Mn